1-20 of 111
Mei-Jie Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation

Clinical Trials & Observations
Leslie S. Kean, Linda J. Burns, Tzuyung D. Kou, Roxanne Kapikian, Karissa Lozenski, Amelia Langston, John T. Horan, Benjamin Watkins, Muna Qayed, Brandi Bratrude, Kayla Betz, Xiao-Ying Tang, Mei-Jie Zhang, Sean E. Connolly, Martin Polinsky, Brian Gavin, Andres Gomez-Caminero, Marcelo C. Pasquini
Journal: Blood
Blood (2024) 144 (17): 1834–1845.
https://doi.org/10.1182/blood.2023023660
Published: 2024
Includes: Supplemental data
Journal Articles

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease

Clinical Trials & Observations
John Magenau, Samantha Jaglowski, Joseph Uberti, Sherif S. Farag, Mary Mansour Riwes, Attaphol Pawarode, Sarah Anand, Monalisa Ghosh, John Maciejewski, Thomas Braun, Martin Devenport, Susan Lu, Bhramori Banerjee, Carolyn DaSilva, Steven Devine, Mei-Jie Zhang, Linda J. Burns, Yang Liu, Pan Zheng, Pavan Reddy
Journal: Blood
Blood (2024) 143 (1): 21–31.
https://doi.org/10.1182/blood.2023020250
Published: 2024
Includes: Supplemental data
Journal Articles

A Real-World Evidence Comparison of 1-Year Overall Survival and Relapse-Free Survival between Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Versus Antithymocyte Globulin or Post-Transplant Cyclophosphamide Following Allogeneic Hematopoietic Cell Transplantation

Leslie S. Kean, Linda J Burns, Tzuyung Douglas Kou, Christopher Bond, Roxanne Kapikian, Karissa Lozenski, Xiao-Ying Tang, Mei-Jie Zhang, Michael T Hemmer, Sean E Connolly, Martin Polinsky, Andres Gomez, Marcelo C Pasquini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1373–1375.
https://doi.org/10.1182/blood-2022-157610
Published: 2022
Journal Articles

Treatment Free Remission after Combination Therapy with Asciminib (ABL001) Plus Imatinib in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed after a Prior Attempt at TKI Discontinuation-H Jean Khoury Cure CML Consortium Study

Michael Mauro, Alexis Visotcky, Kathryn E Flynn, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Jorge E. Cortes, Vamsi K Kota, Srinivas K. Tantravahi, Arielle Baim, Mei-Jie Zhang, Alexander Hinman, Ehab L. Atallah, Kendra Sweet
Journal: Blood
Blood (2022) 140 (Supplement 1): 6765–6766.
https://doi.org/10.1182/blood-2022-160138
Published: 2022
Journal Articles

Asciminib As Initial Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)-H. Jean Khoury Cure CML Consortium Study

Ehab L. Atallah, Alexis Visotcky, Kathryn E Flynn, Mei-Jie Zhang, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Srinivas K. Tantravahi, B. Douglas Douglas Smith, Javier Pinilla Ibarz, Kendra Sweet, Michael Mauro, Brian J. Druker, James E. Thompson, Sonia Maldonado-Schmidt, Arielle Baim, Charles A. Schiffer, Vamsi K. Kota, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 3885–3886.
https://doi.org/10.1182/blood-2022-160172
Published: 2022
Journal Articles

Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real World Evidence

Sandra Cohen, Nadia M. Bambace, Imran Ahmad, Linda J. Burns, Jean Roy, Silvy Lachance, Léa Bernard, Jean-Sébastien Delisle, Denis-Claude Roy, Thomas L. Kiss, Olivier Veilleux, Mei-Jie Zhang, Xiao-Ying Tang, Guy Sauvageau
Journal: Blood
Blood (2022) 140 (Supplement 1): 1610–1612.
https://doi.org/10.1182/blood-2022-160417
Published: 2022
Journal Articles

Younger Matched Unrelated Donors Confer a Decreased Relapse Risk As Compared to Older Sibling Donors for Adult B-Cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Muhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, Karen Chen, Christopher Bredeson, David S. Allan, Mitchell Sabloff, Mark R. Litzow, Partow Kebriaei, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 10540–10541.
https://doi.org/10.1182/blood-2022-163517
Published: 2022
Journal Articles

Late Graft Failure in MDS and Acute Leukemia Patients Receiving Allogenic Hematopoietic Cell Transplantation with Post Transplant Cyclophosphamide As Gvhd Prophylaxis

Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, Rizwan Romee, Filippo Milano, Claudio G. Brunstein, Cara L. Benjamin, Navneet S. Majhail, Stephen R. Spellman, Corey S. Cutler
Journal: Blood
Blood (2022) 140 (Supplement 1): 895–896.
https://doi.org/10.1182/blood-2022-167736
Published: 2022
Journal Articles

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Marcos J.G. de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, Michael T Hemmer, Mei-Jie Zhang, Fan Zhang, Richa Shah, Verna Welch, Saara Tikka, Erik Vandendries, Matthias Stelljes, David I. Marks, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 6023–6025.
https://doi.org/10.1182/blood-2022-160315
Published: 2022
Journal Articles

Comparison of Allogeneic Hematopoietic Cell Transplantation Outcomes from Younger Matched Unrelated Donor Versus Older Sibling Donor for Acute Myeloid Leukemia

Muhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, Karen Chen, David S. Allan, Christopher Bredeson, Mitchell Sabloff, Mark R. Litzow, Partow Kebriaei, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 909–910.
https://doi.org/10.1182/blood-2022-162742
Published: 2022
Journal Articles

Improved Overall Survival of Patients Treated with Abatacept in Combination with a Calcineurin Inhibitor and Methotrexate Following 7/8 HLA-Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of the Center for International Blood and Marrow Transplant Research Database

Leslie S Kean, Linda J Burns, Tzuyung Douglas Kou, Roxanne Kapikian, Xiao-Ying Tang, Mei-Jie Zhang, Michael Hemmer, Sean E Connolly, Martin Polinsky, Brian Gavin, Andres Gomez, Marcelo C Pasquini
Journal: Blood
Blood (2021) 138 (Supplement 1): 3912.
https://doi.org/10.1182/blood-2021-150742
Published: 2021
Journal Articles

Second Treatment Free Remission after Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CML)

Kendra Sweet, Ehab L. Atallah, Jerry P. Radich, Mei-Jie Zhang, Eva Sahakian, Melanie Mediavilla-Varela, Alexis Vistocky, Michael C. Heinrich, James E. Thompson, Michael J. Mauro, Kathryn E Flynn, Arielle Baim, Javier Pinilla Ibarz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2555.
https://doi.org/10.1182/blood-2021-147954
Published: 2021
Journal Articles

Prompt CR Plus Consolidation Therapy Yields Improve Survival after Allogeneic Transplantation for AML Patients Receiving Myeloablative, but Not Reduced-Intensity Conditioning: A CIBMTR Analysis

Michael M. Boyiadzis, Marcos J.G. de Lima, Mei-Jie Zhang, Karen Chen, Christopher S. Hourigan, Partow Kebriaei, Mark R. Litzow, Kristin M. Page, Wael Saber, Daniel J. Weisdorf
Journal: Blood
Blood (2021) 138 (Supplement 1): 414.
https://doi.org/10.1182/blood-2021-149962
Published: 2021
Journal Articles

Prognostic Impact of a Modified European LeukemiaNet (ELN) Genetic Risk Stratification in Predicting Outcomes for Adults with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT). a Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis for the CIBMTR Acute Leukemia Writing Committee

Antonio M. Jimenez, MDMSc, Trent Wang, DO,MPH, Marcos de Lima, MD, Krishna V Komanduri, MD, Partow Kebriaei, MD, Mark Litzow, MD, Vijaya Raj Bhatt, MBBS, Frédéric Baron, MD PhD, Ayman Saad, MD MSc, Nandita Khera, MD, Joseph Maakaron, MD, Hemant S. Murthy, MD, Edward A Copelan, Zachariah Defilipp, MD, Christopher Bredeson, MDFRCPC,MSc, Rodrigo Martino, MD, Maxwell Krem, Taiga Nishihori, MD, Mei-Jie Zhang, PhD, Daniel J. Weisdorf, MD, Karen Chen, MS, Wael Saber, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–29.
https://doi.org/10.1182/blood-2020-137589
Published: 2020
Journal Articles

Impact of Age on the Outcomes of HCT for AML in CR1: Promising Therapy for Older Adults

Joseph Maakaron, MD, Karen Chen, MS, Mei-Jie Zhang, PhD, Christopher S. Hourigan, MDDPhil, Mark Litzow, MD, Wael Saber, MD MS, Partow Kebriaei, MD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-141096
Published: 2020
Journal Articles

Comparison of Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide to Matched-Sibling, Matched-Unrelated, Mismatched-Unrelated, and Umbilical Cord Blood Donor Transplantation in Adults with Acute Lymphoblastic Leukemia: A CIBMTR Study

Matthew J. Wieduwilt, MD PhD, Leland Metheny, III, MD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Noel Estrada-Merly, MS, Marcos de Lima, MD, Mark Litzow, MD, Partow Kebriaei, MD, Chris S. Hourigan, MDPhD, Daniel J. Weisdorf, MD, Wael Saber, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–51.
https://doi.org/10.1182/blood-2020-137186
Published: 2020
Journal Articles

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Clinical Trials & Observations
Matthew J. Frigault, Sarah Nikiforow, Michael K. Mansour, Zhen-Huan Hu, Mary M. Horowitz, Marcie L. Riches, Peiman Hematti, Cameron J. Turtle, Mei-Jie Zhang, Miguel-Angel Perales, Marcelo C. Pasquini
Journal: Blood
Blood (2020) 136 (1): 137–139.
https://doi.org/10.1182/blood.2020006216
Published: 2020
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia

Leland Metheny, III, MD, Wael Saber, MD MS, Daniel J. Weisdorf, MD, Marcos de Lima, MD, Natalie Scott Callander, MD, Mark Litzow, MD, Partow Kebriaei, MD, Aric C. Hall, MD, Brenda M Sandmaier, MD, Mei-Jie Zhang, Hai-Lin Wang, MPH, Khalid Bo-Subait
Journal: Blood
Blood (2019) 134 (Supplement_1): 2036.
https://doi.org/10.1182/blood-2019-125946
Published: 2019
Journal Articles

Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen

Patrick Hagen, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD, Omar Davila, Mei-Jie Zhang, David H. Vesole, MD PhD, Scott E. Smith, MD PhD, Tulio E Rodriguez, MD, Patrick J. Stiff, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2023.
https://doi.org/10.1182/blood-2019-124188
Published: 2019
Journal Articles

Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young Adults with Ph-Negative Acute Lymphoblastic Leukemia in First Complete Remission: Comparison of CALGB 10403 to Patients Reported to the CIBMTR

Matthew J. Wieduwilt, MD PhD, Wendy Stock, MD, Anjali S. Advani, MD, Selina M. Luger, MD FRCPC, Richard A. Larson, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, Mei-Jie Zhang, Khalid Bo-Subait, Brenda M. Sandmaier, MD, Marcos de Lima, MD, Partow Kebriaei, MD, Mark Litzow, MD, Wael Saber, MD MS, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 261.
https://doi.org/10.1182/blood-2019-128560
Published: 2019